July 23, 2007 - CMS Inc. announced the signing of a collaboration agreement to provide treatment planning support for XiO, a new single-room proton beam radiotherapy system being developed by Still River Systems.
CMS and Still River Systems will work together to ensure that CMS’s XiO treatment planning system interfaces with and supports the specific planning requirements of Still River Systems’ Clinatron 250 proton treatment system currently in development.
CMS’ XiO is a comprehensive treatment planning system that reportedly combines the latest tools and the most robust dose calculation algorithms, allowing users to generate treatment plans quickly and accurately to optimize the delivery of radiation therapy. XiO’s integrated planning capabilities support a range of treatment modalities, including 3-D, MLC-based IMRT (both sliding window and step-and-shoot), solid compensator-based IMRT, brachytherapy and proton therapy. XiO leverages the speed and performance capabilities of the Linux operating system and the processing power of dual Intel processors to deliver superior 3-D image rendering, real-time image manipulation, and rapid calculation times.
For more information: www.cmsrtp.com
May 06, 2024 
